Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1961-1969
Published online before print October 20, 2008, doi: 10.1161/CIRCULATIONAHA.108.788240
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/19/1961    most recent
CIRCULATIONAHA.108.788240v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, Y.-T.
Right arrow Articles by Vatner, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, Y.-T.
Right arrow Articles by Vatner, S. F.
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Chronic ischemic heart disease
Right arrowRelated Article

(Circulation. 2008;118:1961-1969.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Repetitive Ischemia by Coronary Stenosis Induces a Novel Window of Ischemic Preconditioning

You-Tang Shen, MD*; Christophe Depre, MD, PhD*; Lin Yan, PhD; Ji Yeon Park, MS; Bin Tian, PhD; Komal Jain, MS; Li Chen, MD; Yan Zhang, MD; Raymond K. Kudej, DVM, PhD; Xin Zhao, MD; Junichi Sadoshima, MD, PhD; Dorothy E. Vatner, MD; Stephen F. Vatner, MD

From the Cardiovascular Research Institute (Y.-T.S., C.D., L.Y., L.C., Y.Z., R.K.K., X.Z., J.S., D.E.V., S.F.V.), Department of Cell Biology and Molecular Medicine and Department of Biochemistry and Molecular Biology (J.Y.P., B.T., K.J.), University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ.

Correspondence to Stephen F. Vatner, MD, University Professor and Chair, Department of Cell Biology and Molecular Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 S Orange Ave, MSB G-609, Newark, NJ 07103. E-mail vatnersf{at}umdnj.edu

Received April 23, 2008; accepted August 29, 2008.

Background— The hypothesis of the present study was that molecular mechanisms differ markedly when mediating ischemic preconditioning induced by repetitive episodes of ischemia versus classic first- or second-window preconditioning.

Methods and Results— To test this, chronically instrumented conscious pigs were subjected to either repetitive coronary stenosis (RCS) or a traditional protocol of second-window ischemic preconditioning (SWIPC). Lethal ischemia, induced by 60 minutes of coronary artery occlusion followed by reperfusion, resulted in an infarct size/area at risk of 6±3% after RCS and 16±3% after SWIPC (both groups P<0.05, less than shams 42±4%). Two molecular signatures of SWIPC, the increased expression of the inducible isoform of nitric oxide synthase and the translocation of protein kinase C{epsilon} to the plasma membrane, were observed with SWIPC but not with RCS. Confirming this, pretreatment with a nitric oxide synthase inhibitor prevented the protection conferred by SWIPC but not by RCS. Microarray analysis revealed a qualitatively different genomic profile of cardioprotection between ischemic preconditioning induced by RCS and that induced by SWIPC. The number of genes significantly regulated was greater in RCS (5739) than in SWIPC (2394) animals. Of the 5739 genes regulated in RCS, only 31% were also regulated in SWIPC. Broad categories of genes induced by RCS but not SWIPC included those involved in autophagy, endoplasmic reticulum stress, and mitochondrial oxidative metabolism. The upregulation of these pathways was confirmed by Western blotting.

Conclusions— RCS induces cardioprotection against lethal myocardial ischemia that is at least as powerful as traditional ischemic preconditioning but is mediated through radically different mechanisms.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1911-1912. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Rane, M. He, D. Sayed, H. Vashistha, A. Malhotra, J. Sadoshima, D. E. Vatner, S. F. Vatner, and M. Abdellatif
Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1{alpha} and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes
Circ. Res., April 10, 2009; 104(7): 879 - 886.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Heusch, K. Boengler, and R. Schulz
Cardioprotection: Nitric Oxide, Protein Kinases, and Mitochondria
Circulation, November 4, 2008; 118(19): 1915 - 1919.
[Full Text] [PDF]